All except one of the cases positive for a PIK3CA mutation at baseline had the same mutation detectable at the end of treatment (1/37 undetectable, 2.7%), consistent with the probable truncal nature of PIK3CA mutations in breast cancer (Fig. 5b). The gene discussed is PIK3CA; the disease is breast carcinoma.